Guided Therapeutics (GTHP) Share-based Compensation (QoQ) (2011 - 2025)
Guided Therapeutics (GTHP) Share-based Compensation (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.37% |
| Sep 30, 2025 | -88.50% |
| Jun 30, 2025 | 691,663.16% |
| Mar 31, 2025 | 100.15% |
| Dec 31, 2024 | -180.52% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | 54,570.00% |
| Mar 31, 2024 | 100.06% |
| Dec 31, 2023 | -414.26% |
| Sep 30, 2023 | -98.46% |
| Jun 30, 2023 | 98.40% |
| Mar 31, 2023 | 46.88% |
| Dec 31, 2022 | 772.73% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -38.03% |
| Dec 31, 2021 | 26.79% |
| Sep 30, 2021 | -6.67% |
| Jun 30, 2021 | -3.23% |
| Mar 31, 2021 | 5.25% |